Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 94, Issue 1, 2011, Pages 156-162

  Shin, Jang Yel ^a   Kim, Soo Ki ^a   Lee, Mi Young ^a   Kim, Hyun Soo ^a   Ye, Byung Il ^a   Shin, Young Goo ^a   Baik, Soon Koo ^a   Chung, Choon Hee ^a  

^a Yonsei University Wonju   (South Korea)

Author keywords

NAFLD; SHBG; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT ESTIMATED INSULIN RESISTANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; ALANINE TRANSAMINASE; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN;

EID: 80054888593     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.07.029     Document Type: Article

References (32)

1. Meigs J.B., Wilson P.W., Fox C.S., Vasan R.S., Nathan D.M., Sullivan L.M., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006, 91:2906-2912.
2. Malik S., Wong N.D., Franklin S., Pio J., Fairchild C., Chen R. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005, 28:690-693.
3. Despres J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
4. Medina J., Fernandez-Salazar L.I., Garcia-Buey L., Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004, 27:2057-2066.
5. Kotronen A., Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008, 28:27-38.
6. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007, 102:2708-2715.
7. Shibata M., Kihara Y., Taguchi M., Tashiro M., Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007, 30:2940-2944.
8. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
9. Sorensen K., Aksglaede L., Munch-Andersen T., Aachmann-Andersen N.J., Petersen J.H., Hilsted L., et al. Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. Diabetes Care 2009, 32:909-914.
10. Laaksonen D.E., Niskanen L., Punnonen K., Nyyssonen K., Tuomainen T.P., Salonen R., et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol 2003, 149:601-608.
11. Kalyani R.R., Franco M., Dobs A.S., Ouyang P., Vaidya D., Bertoni A., et al. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 2009, 94:4127-4135.
12. Ding E.L., Song Y., Manson J.E., Hunter D.J., Lee C.C., Rifai N., et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009, 361:1152-1163.
13. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., Chae C., Lasley B.L., Brockwell S., et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005, 111:1242-1249.
14. Selva D.M., Hogeveen K.N., Innis S.M., Hammond G.L. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 2007, 117:3979-3987.
15. Selva D.M., Hammond G.L. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4α. J Mol Endocrinol 2009, 43:19-27.
16. Perry J.R., Weedon M.N., Langenberg C., Jackson A.U., Lyssenko V., Sparsø T., et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 2010, 19:535-544.
17. Stefan N., Schick F., Haring H.U. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med 2009, 361:2675-2676.
18. Joseph A.E., Saverymuttu S.H., al-Sam S., Cook M.G., Maxwell J.D. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991, 43:26-31.
19. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clinical research ed.) 1986, 292:13-15.
20. Mehta S.R., Thomas E.L., Patel N., Crofton M.E., McCarthy J., Eliahoo J., et al. Proton magnetic resonance spectroscopy and ultrasound for hepatic fat quantification. Hepatol Res 2010, 40:399-406.
21. Vassilatou E., Lafoyianni S., Vryonidou A., Ioannidis D., Kosma L., Katsoulis K., et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod 2010, 25:212-220.
22. Peter A., Kantartzis K., Machann J., Schick F., Staiger H., Machicao F., et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010, 59:3167-3173.
23. Onat A., Hergenc G., Karabulut A., Albayrak S., Can G., Kaya Z. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. Metabolism 2007, 56:1356-1362.
24. Garces C., de Oya I., Lasuncion M.A., Lopez-Simon L., Cano B., de Oya M. Sex hormone-binding globulin and lipid profile in pubertal children. Metabolism 2010, 59:166-171.
25. Toledo F.G., Sniderman A.D., Kelley D.E. Influence of hepatic steatosi (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 2006, 29:1845-1850.
26. Hossain N., Afendy A., Stepanova M., Nader F., Srishord M., Rapiq N., et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009, 7:1224-1229.
27. Leite N.C., Villela-Nogueira C.A., Pannain V., Bottino A.C., Rezende G., Cardoso C., et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalence and correlated factors. Liver Int 2011, 31:700-706.
28. Miyaaki H., Ichikawa T., Nakao K., Yatsuhashi H., Furukawa R., Ohba K., et al. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int 2008, 28:519-524.
29. Agarwal A.K., Jain V., Singla S., Baruah B.P., Arya V., Yadav R., et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011, 59:1-4.
30. Gaiani S., Avogaro A., Bombonato G.C., Bolognesi M., Amor F., Vigili de Kreutzenberg S., et al. Nonalcoholic fatty liver disease (NAFLD) in nonobese patients with diabetes: prevalence and relationships with hemodynamic alterations detected with Doppler sonography. J Ultrasound 2009, 12:1-5.
31. Hosseinpanah F., Rambod M., Sadeghi L. Predictors of non-alcoholic fatty liver disease in type 2 diabetes. Int J Endocrinol Metab 2007, 2:61-69.
32. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.